{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:02:07Z","timestamp":1789502527440,"version":"build-2803163510"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Hebei Natural Science Foundation","award":["H2020206365 and H2021206071"],"award-info":[{"award-number":["H2020206365 and H2021206071"]}]},{"name":"S&T Program of Hebei","award":["236Z7719G"],"award-info":[{"award-number":["236Z7719G"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    This study examined the risk factors associated with the prognosis and analyzed the prognostic impact of axillary lymph node dissection (ALND) or radiotherapy on patients with sentinel lymph node (SLN) micrometastases to identify specific populations in which ALND can be omitted. A retrospective analysis of patients with pT1\u20133N1miM0 breast cancer was conducted. Patients were divided into SLN biopsy (SLNB) and SLNB\u2005+\u2005ALND groups. Cox proportional hazard model and logistic regression analyses were performed to identify independent risk factors associated with survival. Propensity score matching was performed to balance patient characteristics. The Kaplan\u2013Meier method was used to plot survival curves. Of the 320 patients enrolled, 104 cases in each group were successfully matched. There were no differences in locoregional recurrence rate (LRR), disease-free survival, or overall survival between the SLNB and SLNB\u2005+\u2005ALND groups. Univariate and multivariate analyses identified progesterone receptor-negative status (odds ratio\u2005=\u200525, 95% confidence interval, 1.27\u2013Inf,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.035) and lymph vascular invasion (odds ratio\u2005=\u200577.21, 95% confidence interval, 6.30\u2013945.65,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) as risk factors for LRR, but these factors were no longer risk factors after propensity score matching. When the SLNB or SLNB\u2005+\u2005ALND groups were further divided into radiotherapy and no-radiotherapy subgroups, radiotherapy was found to have no effect on prognosis. Neither ALND nor radiotherapy impacts the LRR, disease-free survival, or overall survival of patients with breast cancer with SLN micrometastases. Local treatment, such as ALND or radiotherapy, is recommended for patients with SLN micrometastases with risk factors such as progesterone receptor-negative status or lymph vascular invasion if subsequent systemic treatment cannot be guaranteed.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045011","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:04:44Z","timestamp":1762211084000},"page":"e45011","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study on axilla treatment for breast cancer with sentinel lymph node micrometastases"],"prefix":"10.1097","volume":"104","author":[{"given":"Xueyi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanle","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchuan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"937","DOI":"10.6004\/jnccn.2020.5005","article-title":"Locoregional management of early-stage breast cancer.","volume":"18","author":"Anderson","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.path.2021.11.002","article-title":"Pathologic evaluation of lymph nodes in breast cancer: contemporary approaches and clinical implications.","volume":"15","author":"Balla","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"R4-20260915","first-page":"125","article-title":"Surgical treatment for breast cancer and axillary metastases: historical perspective.","volume":"19","author":"Grebi\u0107","year":"2021","journal-title":"Acta Med Hist Adriat"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10549-021-06162-2","article-title":"Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.","volume":"187","author":"Hetterich","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00428-018-2301-9","article-title":"The new TNM-based staging of breast cancer.","volume":"472","author":"Cserni","year":"2018","journal-title":"Virchows Arch"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"1012646","DOI":"10.3389\/fonc.2022.1012646","article-title":"The prognostic significance of further axillary dissection for sentinel lymph node micrometastases in female breast cancer: a competing risk analysis using the SEER database.","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","article-title":"Micrometastases or isolated tumor cells and the outcome of breast cancer.","volume":"361","author":"de Boer","year":"2009","journal-title":"N Engl J Med"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bjs\/znab141","article-title":"Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.","volume":"108","author":"Andersson","year":"2021","journal-title":"Br J Surg"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial.","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial.","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1245\/s10434-007-9361-4","article-title":"Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer.","volume":"14","author":"Van Zee","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1245\/s10434-017-5866-7","article-title":"Axillary micrometastases and isolated tumor cells are not an indication for post-mastectomy radiotherapy in stage 1 and 2 Breast Cancer.","volume":"24","author":"Mamtani","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000.","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R15-20260915","first-page":"e933275","article-title":"Impact of post-mastectomy radiation therapy for sentinel lymph node micrometastases in early-stage breast cancer patients.","volume":"28","author":"Luo","year":"2022","journal-title":"Med Sci Monit"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10549-013-2617-8","article-title":"Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years\u2019 follow-up.","volume":"140","author":"Falck","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1245\/s10434-023-13942-1","article-title":"Extremely low incidence of local-regional recurrences observed among T1-2 N1 (1 or 2 Positive SLNs) breast cancer patients receiving upfront mastectomy without completion axillary node dissection.","volume":"30","author":"Zaveri","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10549-018-4840-9","article-title":"Extent of regional lymph node surgery and impact on outcomes in patients with early-stage breast cancer and limited axillary disease undergoing mastectomy.","volume":"171","author":"Picado","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","article-title":"Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy.","volume":"24","author":"FitzSullivan","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10549-021-06341-1","article-title":"Outcomes of Stage I and II breast cancer with nodal micrometastases treated with mastectomy without axillary therapy.","volume":"189","author":"Lim","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1245\/s10434-018-6632-1","article-title":"Post-mastectomy radiation therapy in breast cancer patients with nodal micrometastases.","volume":"25","author":"Wu","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-018-4820-0","article-title":"Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.","volume":"171","author":"Andersson","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/bjc.2016.283","article-title":"Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.","volume":"115","author":"Houvenaeghel","year":"2016","journal-title":"Br J Cancer"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"FSO303","DOI":"10.4155\/fsoa-2018-0008","article-title":"Prognostic significance of further axillary dissection in breast cancer patients with micrometastases & the number of micrometastases: a SEER population-based analysis.","volume":"4","author":"Ying-Ying","year":"2018","journal-title":"Future Sci OA"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12957-023-03082-x","article-title":"Prognosis and local treatment strategies of breast cancer patients with different numbers of micrometastatic lymph nodes.","volume":"21","author":"Luo","year":"2023","journal-title":"World J Surg Oncol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1245\/s10434-021-10374-7","article-title":"Prognosis and chemotherapy use in breast cancer patients with multiple lymphatic micrometastases: an NCDB analysis.","volume":"28","author":"Weiser","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s12262-023-03888-9","article-title":"Prognostic impacts of the localization and diameter of breast cancer axillary micrometastasis.","volume":"85","author":"Baysal","year":"2023","journal-title":"Indian J Surg"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.breast.2014.04.004","article-title":"Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.","volume":"23","author":"Houvenaeghel","year":"2014","journal-title":"Breast"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"100151","DOI":"10.1016\/j.esmoop.2021.100151","article-title":"Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort.","volume":"6","author":"Houvenaeghel","year":"2021","journal-title":"ESMO Open"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clbc.2022.01.001","article-title":"De-escalating locoregional therapy for axillary micrometastases in breast cancer: how much is too much?","volume":"22","author":"Merfeld","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1016\/j.ijrobp.2010.12.020","article-title":"Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.","volume":"81","author":"Lupe","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/cncr.22069","article-title":"Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.","volume":"107","author":"van Rijk","year":"2006","journal-title":"Cancer"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.breast.2012.02.012","article-title":"Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.","volume":"21","author":"Boler","year":"2012","journal-title":"Breast"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.semdp.2022.06.016","article-title":"Update on sentinel node pathology in breast cancer.","volume":"39","author":"Harrison","year":"2022","journal-title":"Semin Diagn Pathol"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12262-021-03179-1","article-title":"Results of locoregional radiotherapy or axillary dissection in early breast cancer with pN0(is +) and pN1mi nodal disease.","volume":"84","author":"Altinok","year":"2022","journal-title":"Indian J Surg"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2022.11.017","article-title":"Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: subgroup analysis of the SCCAN project.","volume":"168","author":"Dost\u00e1lek","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"40","DOI":"10.6004\/jnccn.2020.7597","article-title":"Impact of axillary dissection among patients with sentinel node-positive breast cancer undergoing mastectomy.","volume":"19","author":"Sun","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/14737140.2019.1660165","article-title":"Controversies in locoregional management of breast cancer with low volume pN0(i+) and pN1mi nodal disease.","volume":"19","author":"Dosani","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cam4.5257","article-title":"The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.","volume":"12","author":"Houvenaeghel","year":"2023","journal-title":"Cancer Med"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1245\/s10434-019-07388-7","article-title":"Evolution of the use of completion axillary lymph node dissection in patients with T1\/2N0M0 breast cancer and tumour-involved sentinel lymph nodes undergoing mastectomy: a cohort study.","volume":"26","author":"Hennigs","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial.","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"905437","DOI":"10.3389\/fsurg.2022.905437","article-title":"Evaluation of adjuvant therapy for T1-2N1miM0 breast cancer without further axillary lymph node dissection.","volume":"9","author":"Li","year":"2022","journal-title":"Front Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:02:32Z","timestamp":1789498952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":43,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045011","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-05-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}